Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics
2005
Purpose
It is generally assumed that the biodistribution and pharmacokinetics of radiolabelled antibodies remain similar between dosimetric and therapeutic injections in radioimmunotherapy. However, circulation half-lives of unlabelled rituximab have been reported to increase progressively after the weekly injections of standard therapy doses. The aim of this study was to evaluate the evolution of the pharmacokinetics of repeated 131I-rituximab injections during treatment with unlabelled rituximab in patients with non-Hodgkin’s lymphoma (NHL).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
7
Citations
NaN
KQI